First Trust Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$132M Sell
234,653
-1,458
-0.6% -$935K 0.09% 266
2025
Q4
$160M Buy
236,111
+5,924
+3% +$4.03M 0.12% 210
2025
Q3
$147M Sell
230,187
-24,366
-10% -$14.8M 0.11% 220
2025
Q2
$137M Buy
254,553
+35,526
+16% +$17M 0.11% 224
2025
Q1
$92M Buy
219,027
+5,921
+3% +$2.57M 0.08% 298
2024
Q4
$88.1M Buy
213,106
+16,656
+8% +$7.31M 0.08% 308
2024
Q3
$99.3M Buy
196,450
+27,012
+16% +$13.1M 0.09% 242
2024
Q2
$82.6M Sell
169,438
-37,540
-18% -$18.8M 0.08% 253
2024
Q1
$112M Buy
206,978
+48,126
+30% +$26.3M 0.11% 202
2023
Q4
$88.2M Sell
158,852
-23,182
-13% -$10.9M 0.1% 257
2023
Q3
$79.6M Sell
182,034
-24,165
-12% -$12.1M 0.09% 269
2023
Q2
$104M Buy
206,199
+32,808
+19% +$15.7M 0.12% 217
2023
Q1
$86.7M Sell
173,391
-1,954
-1% -$935K 0.1% 275
2022
Q4
$71.5M Sell
175,345
-6,533
-4% -$2.54M 0.09% 368
2022
Q3
$59.3M Buy
181,878
+52,777
+41% +$19.4M 0.08% 399
2022
Q2
$45.3M Sell
129,101
-13,663
-10% -$5.57M 0.06% 469
2022
Q1
$78.1M Sell
142,764
-32,778
-19% -$17.2M 0.08% 338
2021
Q4
$116M Sell
175,542
-4,623
-3% -$2.9M 0.11% 216
2021
Q3
$112M Buy
180,165
+42,648
+31% +$28.7M 0.12% 218
2021
Q2
$86.8M Sell
137,517
-29,854
-18% -$16.5M 0.09% 278
2021
Q1
$81.9M Sell
167,371
-7,962
-5% -$3.99M 0.1% 264
2020
Q4
$87.6M Buy
175,333
+4,521
+3% +$2.02M 0.12% 216
2020
Q3
$67.1M Sell
170,812
-25,976
-13% -$9.6M 0.11% 242
2020
Q2
$65M Buy
196,788
+85,797
+77% +$24.8M 0.11% 224
2020
Q1
$26.9M Sell
110,991
-61,524
-36% -$16.1M 0.06% 438
2019
Q4
$45M Sell
172,515
-43,988
-20% -$11.6M 0.08% 415
2019
Q3
$58.9M Buy
216,503
+74,798
+53% +$20.8M 0.11% 244
2019
Q2
$39M Sell
141,705
-28,290
-17% -$6.97M 0.07% 341
2019
Q1
$38M Sell
169,995
-102,285
-38% -$21.1M 0.08% 331
2018
Q4
$50.6M Buy
272,280
+52,793
+24% +$10.8M 0.12% 208
2018
Q3
$54.8M Buy
219,487
+2,980
+1% +$723K 0.1% 224
2018
Q2
$47.2M Buy
216,507
+81,314
+60% +$16.8M 0.1% 230
2018
Q1
$25.9M Sell
135,193
-23,539
-15% -$4.34M 0.06% 420
2017
Q4
$24.8M Sell
158,732
-98,878
-38% -$15.6M 0.06% 450
2017
Q3
$40.1M Sell
257,610
-69,141
-21% -$10.9M 0.1% 222
2017
Q2
$52.7M Sell
326,751
-15,088
-4% -$2.45M 0.14% 158
2017
Q1
$52.9M Sell
341,839
-26,592
-7% -$3.67M 0.15% 126
2016
Q4
$43.2M Buy
368,431
+2,107
+0.6% +$240K 0.13% 167
2016
Q3
$41.3M Buy
366,324
+106,246
+41% +$11.2M 0.12% 178
2016
Q2
$24.2M Buy
260,078
+143,233
+123% +$12.3M 0.08% 340
2016
Q1
$9.15M Sell
116,845
-773,069
-87% -$55.7M 0.03% 690
2015
Q4
$64.9M Buy
889,914
+853,235
+2,326% +$60.9M 0.17% 132
2015
Q3
$2.72M Sell
36,679
-822,338
-96% -$58.9M 0.01% 1225
2015
Q2
$55.1M Sell
859,017
-47,895
-5% -$3.32M 0.14% 145
2015
Q1
$70M Buy
906,912
+836,910
+1,196% +$65.1M 0.21% 102
2014
Q4
$5.19M Sell
70,002
-655,586
-90% -$46M 0.02% 1018
2014
Q3
$42.7M Buy
725,588
+73,180
+11% +$4.63M 0.17% 117
2014
Q2
$43.6M Buy
652,408
+424,378
+186% +$27M 0.18% 111
2014
Q1
$13.8M Buy
228,030
+154,768
+211% +$9.22M 0.06% 506
2013
Q4
$3.9M Buy
73,262
+17,724
+32% +$933K 0.02% 1066
2013
Q3
$2.77M Buy
55,538
+834
+2% +$40.1K 0.02% 1112
2013
Q2
$2.45M Buy
+54,704
New +$2.39M 0.02% 1096

Other funds holding IDXX

First Trust Advisors's IDXX Position: Q1 2026 in Review

First Trust Advisors reduced its Idexx Laboratories (IDXX) stake by 0.62% in Q1 2026, selling an estimated $935K and leaving 234,653 shares worth $132M. The position accounts for 0.09% of the portfolio, ranked #266.

First Trust Advisors first reported a position in IDXX in Q2 2013 and has held it in 52 quarters since. The position peaked at $160M in Q4 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • First Trust Advisors held 234,653 shares of Idexx Laboratories worth $132M as of Q1 2026.
  • First Trust Advisors sold 1,458 Idexx Laboratories shares in Q1 2026, an estimated $935K.
  • Idexx Laboratories made up 0.09% of First Trust Advisors's portfolio in Q1 2026, its #266 holding.
  • First Trust Advisors first reported a position in Idexx Laboratories in Q2 2013 and has held it in 52 quarters since.
  • First Trust Advisors's Idexx Laboratories position peaked at $160M in Q4 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on First Trust Advisors's 13F filing for Q1 2026, filed 13 May 2026.